Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	Fly Intel: Pre-market Movers » 08:54 02/02/23 02/02 08:54 02/02/23 08:54 FDX FedEx $202.08 / +8.21 (+4.23%) , BMY Bristol-Myers $71.22 / -1.43 (-1.97%) , HSY Hershey $225.25 / +0.78 (+0.35%) , HOG Harley-Davidson $46.78 / +0.74 (+1.61%) , META Meta Platforms $153.10 / +4.135 (+2.78%) , ALGN Align Technology $282.22 / +12.72 (+4.72%) , LLY Eli Lilly $342.49 / -1.61 (-0.47%) , MRK Merck $106.94 / -0.48 (-0.45%) , HON Honeywell $206.67 / -1.87 (-0.90%) , EL Estee Lauder $280.46 / +3.53 (+1.27%) , SIRI Sirius XM $5.84 / +0.06 (+1.04%) , DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) , PENN Penn Entertainment $35.82 / +0.385 (+1.09%) , QRVO Qorvo $113.56 / +4.91 (+4.52%) Check out this morning's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SIRI QRVO PENN MRK META LLY HSY HON HOG FDX EL DGX BMY ALGN SIRI Sirius XM $5.84 / +0.06 (+1.04%) 11/01/22 Sirius XM continues to expect positive 2022 self-pay net subscriber additions 11/01/22 Sirius XM reports Q3 self-pay subscribers 32.3M 11/01/22 Sirius XM raises quarterly cash dividend 10% 10/31/22 Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles QRVO Qorvo $113.56 / +4.91 (+4.52%) 08:23 Today Qorvo introduces three-stage power solution for phased array systems 11/28/22 Qorvo partners with MediaTek to secure design wins 11/02/22 Qorvo, SK Siltron CSS enter SiC supply agreement 11/02/22 Qorvo announces $2B share repurchase program PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 12/29/22 Nevada reports November statewide gaming win down 7.62% to $1.22B 12/20/22 New Jersey reports November gaming revenue up 0.3% to $441.1M 12/08/22 Penn Entertainment announces $750M share buyback program MRK Merck $106.94 / -0.48 (-0.45%) 06:39 Today Merck reports Q4 Keytruda sales $5.45B vs. $4.58B a year ago 06:32 Today Merck sees FY23 adjusted gross margin about 77% 01/27/23 Merck's Keytruda approved by FDA for non-small cell lung cancer treatment 01/26/23 Merck Animal Health announces FDA approval for Bravecto Chews for Dogs META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B 02/01/23 Meta says 2023 will be 'a year of efficiency' 02/01/23 Meta Platforms announces $40B increase in share repurchase authorization 02/01/23 Meta Platforms reports FoA and RL segment restructuring charges LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/27/23 Eli Lilly says FDA approves Jaypirca 01/24/23 Eli Lilly trading resumes 01/24/23 Eli Lilly trading halted, volatility trading pause 01/24/23 Eli Lilly to invest $450M to expand manufacturing at Research Triangle Park HSY Hershey $225.25 / +0.78 (+0.35%) 12/07/22 Hershey announces first bilingual manufacturing facility 10/20/22 Hershey signs new solar power purchase agreement with National Grid Renewables 08/31/22 Hershey names Marlene Creighton as Global Chief Sales Officer HON Honeywell $206.67 / -1.87 (-0.90%) 08:53 Today Honeywell to continue to drive pricing actions to offset cost inflation 08:52 Today Honeywell: Supply chain remains constraint on overall growth 08:48 Today Honeywell sees moderation in raw material inflation in 2023 08:47 Today Honeywell sees continuation of 'many' challenges faced in 2022 HOG Harley-Davidson $46.78 / +0.74 (+1.61%) 08:26 Today Harley-Davidson sees FY23 HDMC revenue growth 4%-7% 01/18/23 Harley-Davidson reveals anniversary models plus four new motorcycles for 2023 10/26/22 Harley-Davidson says had strong recovery in units 09/27/22 Harley-Davidson, AEA-Bridges Impact Corp. complete business combination FDX FedEx $202.08 / +8.21 (+4.23%) 12/23/22 FedEx warns potential delays possible for packages due Dec. 23 and 24 12/20/22 FedEx says drop in volume accelerated through Q2 12/20/22 FedEx remains confident in high capture rate 12/20/22 FedEx says Ground service now back to pre-pandemic levels EL Estee Lauder $280.46 / +3.53 (+1.27%) 11/15/22 Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder 11/15/22 Estee Lauder to acquire TOM FORD brand 11/02/22 Estee Lauder raises quarterly dividend 10% to 66c from 60c per share 11/01/22 Mondelez announces three new members to senior management team DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 07:10 Today Quest Diagnostics raises quarterly dividend, increases share repurchase program 01/23/23 Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test 12/08/22 Quest Diagnostics partners with Northern Light Health in Maine 12/01/22 Quest Diagnostics awarded group purchasing agreement by Premier BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 08:09 Today Exscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology board authorizes $1B buyback to succeed current program 10/31/22 Align Technology CEO Joe Hogan to purchase additional $2M of common stock 10/31/22 Align Technology announces $200M accelerated share repurchase agreement 10/26/22 Align Technology falls 20% to $177.50 after Q3 results misses estimates FDX BMY HSY HOG META ALGN LLY MRK HON EL SIRI DGX PENN QRVO FDX FedEx $202.08 / +8.21 (+4.23%) 06:20 Today BofA FedEx upgraded to Buy from Neutral at BofA 06:04 Today BofA FedEx upgraded to Buy from Neutral at BofA 04:32 Today Citi FedEx upgraded to Buy from Neutral at Citi 02/01/23 Morgan Stanley Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse HSY Hershey $225.25 / +0.78 (+0.35%) 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI 01/03/23 Wells Fargo Hershey initiated with an Underweight at Wells Fargo 12/20/22 Morgan Stanley Hershey price target raised to $231 from $224 at Morgan Stanley 12/08/22 UBS Hershey upgraded to Buy from Neutral at UBS HOG Harley-Davidson $46.78 / +0.74 (+1.61%) 12/22/22 DA Davidson Harley-Davidson price target raised to $44 from $42 at DA Davidson 11/15/22 Jefferies Harley-Davidson initiated with an Underperform at Jefferies 10/27/22 DA Davidson Harley-Davidson price target raised to $42 from $36 at DA Davidson 10/27/22 Baird Harley-Davidson price target raised to $48 from $45 at Baird META Meta Platforms $153.10 / +4.135 (+2.78%) 08:45 Today RBC Capital Meta Platforms price target raised to $225 from $160 at RBC Capital 08:30 Today Needham Meta Platforms reported fundamentals still deteriorating, says Needham 08:25 Today Jefferies Meta Platforms price target raised to $225 from $175 at Jefferies 08:12 Today Guggenheim Meta Platforms price target raised to $210 from $130 at Guggenheim ALGN Align Technology $282.22 / +12.72 (+4.72%) 07:44 Today Stifel Align Technology price target raised to $375 from $265 at Stifel 07:04 Today Goldman Sachs Goldman ups Align Technology to Neutral on more confidence in near-term demand 07:00 Today Goldman Sachs Align Technology upgraded to Neutral from Sell at Goldman Sachs 06:50 Today Baird Align Technology price target raised to $335 from $260 at Baird LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/20/23 William Blair Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair 01/12/23 Guggenheim Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks 01/03/23 Barclays Eli Lilly price target raised to $400 from $395 at Barclays 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James MRK Merck $106.94 / -0.48 (-0.45%) 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/04/23 BofA Merck upgraded to Buy at BofA on consistent revenue upside 01/04/23 BofA Merck upgraded to Buy from Neutral at BofA 01/03/23 Wells Fargo Merck price target raised to $125 from $110 at Wells Fargo HON Honeywell $206.67 / -1.87 (-0.90%) 01/04/23 UBS Honeywell downgraded to Sell from Buy at UBS 12/09/22 Citi Honeywell price target raised to $248 from $213 at Citi 12/05/22 Deutsche Bank Honeywell price target raised to $242 from $227 at Deutsche Bank 12/01/22 Barclays Honeywell price target raised to $229 from $212 at Barclays EL Estee Lauder $280.46 / +3.53 (+1.27%) 01/31/23 Jefferies Bath & Body Works price target raised to $52 from $45 at Jefferies 01/24/23 Stifel Estee Lauder price target raised to $295 from $255 at Stifel 01/23/23 Deutsche Bank Estee Lauder price target raised to $290 from $266 at Deutsche Bank 01/17/23 Oppenheimer Estee Lauder price target raised to $300 from $245 at Oppenheimer SIRI Sirius XM $5.84 / +0.06 (+1.04%) 01/03/23 JPMorgan Sirius estimates cut on 'challenged' advertising market at JPMorgan 12/01/22 Citi Sirius XM downgraded to Sell from Buy at Citi 11/02/22 Deutsche Bank Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank 11/02/22 Pivotal Research Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 01/23/23 Evercore ISI Quest Diagnostics initiated with an In Line at Evercore ISI 01/12/23 Baird Quest Diagnostics price target raised to $154 from $143 at Baird 12/14/22 Mizuho Quest Diagnostics price target raised to $165 from $160 at Mizuho 11/17/22 Citi Quest Diagnostics downgraded to Sell from Neutral at Citi PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/20/23 JMP Securities Penn Entertainment price target lowered to $45 from $48 at JMP Securities 01/11/23 Truist Penn Entertainment price target lowered to $36 from $40 at Truist 01/09/23 Jefferies Penn Entertainment downgraded to Hold at Jefferies as focus narrows 01/09/23 Jefferies Penn Entertainment downgraded to Hold from Buy at Jefferies QRVO Qorvo $113.56 / +4.91 (+4.52%) 08:50 Today Craig-Hallum Qorvo price target raised to $130 from $120 at Craig-Hallum 07:37 Today BMO Capital Qorvo price target raised to $105 from $90 at BMO Capital 07:28 Today Cowen Qorvo price target raised to $100 from $80 at Cowen 07:24 Today Morgan Stanley Qorvo price target raised to $110 from $87 at Morgan Stanley SIRI QRVO PENN MRK META LLY HSY HON HOG FDX EL DGX BMY ALGN SIRI Sirius XM $5.84 / +0.06 (+1.04%) 07:07 Today Sirius XM sees FY23 revenue $9.0B, consensus $9.29B 07:05 Today Sirius XM reports Q4 EPS 9c, consensus 8c QRVO Qorvo $113.56 / +4.91 (+4.52%) 02/01/23 Qorvo sees Q4 EPS 10c-15c, consensus 64c 02/01/23 Qorvo reports Q3 EPS 75c, consensus 63c 11/02/22 Qorvo sees Q3 EPS 50c-75c, consensus $1.69 PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 07:10 Today Penn Entertainment reports Q4 EPS 13c, consensus 41c 11/03/22 Penn Entertainment reports Q3 EPS 72c, consensus 38c MRK Merck $106.94 / -0.48 (-0.45%) 06:31 Today Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 06:30 Today Merck reports Q4 adjusted EPS $1.62, consensus $1.54 META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B LLY Eli Lilly $342.49 / -1.61 (-0.47%) 06:54 Today Eli Lilly raises FY23 adjusted EPS view to $8.35-$8.55 from $8.10-$8.30 06:50 Today Eli Lilly reports Q4 adjusted EPS $2.09, consensus $1.78 HSY Hershey $225.25 / +0.78 (+0.35%) 07:02 Today Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94 07:00 Today Hershey reports Q4 adjusted EPS $2.02, consensus $1.77 HON Honeywell $206.67 / -1.87 (-0.90%) 06:47 Today Honeywell sees Q1 adjusted EPS $1.86-$1.96, consensus $2.03 06:45 Today Honeywell sees FY23 adjusted EPS $8.80-$9.20, consensus $9.13 06:42 Today Honeywell reports Q4 adjusted EPS $2.52, consensus $2.51 HOG Harley-Davidson $46.78 / +0.74 (+1.61%) 07:01 Today Harley-Davidson reports Q4 EPS 28c, consensus 6c 10/26/22 Harley-Davidson reaffirms FY22 revenue view increase 5%-10% 10/26/22 Harley-Davidson reports Q3 GAAP EPS $1.78, consensus $1.40 10/25/22 Notable companies reporting before tomorrow's open FDX FedEx $202.08 / +8.21 (+4.23%) 12/20/22 FedEx sees FY23 EPS before-MTM ex-costs $13-$14, consensus $14.08 12/20/22 FedEx reports Q2 adjusted EPS $3.18, consensus $2.82 12/20/22 Notable companies reporting after market close 09/22/22 FedEx reports Q1 Express revenue $11.127B, up 1% EL Estee Lauder $280.46 / +3.53 (+1.27%) 06:48 Today Estee Lauder sees FY23 adjusted EPS $4.87-$5.02, consensus $5.35 06:47 Today Estee Lauder sees Q3 adjusted EPS 37c-47c, consensus $1.77 06:46 Today Estee Lauder reports Q2 adjusted EPS $1.54, consensus $1.30 06:45 Today Estee Lauder reports Q2 diluted EPS $1.09, consensus $1.30 DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 06:58 Today Quest Diagnostics sees FY23 adjusted EPS $8.40-$9.00, consensus $8.69 06:56 Today Quest Diagnostics reports Q4 adjusted EPS $1.98, consensus $1.91 BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 07:03 Today Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 07:02 Today Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 02/01/23 Notable companies reporting before tomorrow's open ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology reports Q4 EPS $1.73, consensus $1.56 10/26/22 Align Technology reports Q3 adjusted EPS $1.36, consensus $2.18 SIRI MRK META LLY HSY HON FDX EL DGX BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 12/01/22 Sirius XM to cut staff amid faltering sales growth, Bloomberg reports 12/01/22 Sirius XM to reduce staff in coming weeks, Bloomberg reports 08/31/22 James Van Der Beek sues SiriusXM over podcast deal, THR reports MRK Merck $106.94 / -0.48 (-0.45%) 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Meta wins approval over FTC to acquire Within Unlimited, Bloomberg says 02/01/23 Meta debates on whether to share Reel money with creators, Information reports 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says LLY Eli Lilly $342.49 / -1.61 (-0.47%) 12/19/22 Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports 10/11/22 New quality issues found at Eli Lilly drug plant, Reuters reports 08/13/22 Eli Lilly, Novo Nordisk weight-loss drugs could be blockbusters, Barron's says HSY Hershey $225.25 / +0.78 (+0.35%) 12/30/22 Hershey sued over metals content in dark chocolate, Reuters says 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure HON Honeywell $206.67 / -1.87 (-0.90%) 09/19/22 Defense companies urged to limit use of Chinese supplies, WSJ reports FDX FedEx $202.08 / +8.21 (+4.23%) 02/01/23 FedEx cutting management positions by over 10%, Bloomberg reports 02/01/23 FedEx cutting management positions by over 10%, Bloomberg reports 01/10/23 FedEx reduces Sunday deliveries 'again' amid e-commerce decline, Bloomberg says 10/07/22 FedEx ground division to lower volume forecast, Reuters says EL Estee Lauder $280.46 / +3.53 (+1.27%) 11/16/22 Zegna to acquire rest of Tom Ford International, Bloomberg reports 11/15/22 Estee Lauder to acquire Tom Ford in deal valued at $2.8B, WSJ reports 11/15/22 Estee Lauder nearing deal to acquire Tom Ford for $2.8B, WSJ reports 11/11/22 Estee Lauder near deal to acquire Tom Ford for $2.8B, FT reports DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 12/19/22 Doctors gain confidence in new Alzheimer's blood tests, Bloomberg reports BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports SIRI QRVO PENN MRK META LLY HSY HON HOG FDX EL DGX BMY ALGN SIRI Sirius XM $5.84 / +0.06 (+1.04%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/01/22 Fly Intel: Pre-market Movers QRVO Qorvo $113.56 / +4.91 (+4.52%) 11/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/05/22 Buy/Sell: Wall Street's top 10 stock calls this week PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/20/23 Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization 01/13/23 Bet On It: PlayUp SPAC deal terminated 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/06/23 Bet On It: Three downstate New York casino licenses now up for grabs MRK Merck $106.94 / -0.48 (-0.45%) 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Fly Intel: After-Hours Movers 02/01/23 #SocialStocks: Meta circumvents FTC challenge and will acquire Within Unlimited 02/01/23 What You Missed On Wall Street This Morning LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/23/23 Biotech Alert: Searches spiking for these stocks today 01/20/23 What You Missed On Wall Street This Morning 01/20/23 Fly Intel: Pre-market Movers 12/19/22 What You Missed On Wall Street On Monday HSY Hershey $225.25 / +0.78 (+0.35%) 01/07/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning HON Honeywell $206.67 / -1.87 (-0.90%) 11/18/22 What You Missed On Wall Street On Friday HOG Harley-Davidson $46.78 / +0.74 (+1.61%) 11/15/22 What You Missed On Wall Street On Tuesday 11/15/22 What You Missed On Wall Street This Morning 11/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/15/22 Fly Intel: Pre-market Movers FDX FedEx $202.08 / +8.21 (+4.23%) 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 Here's what Wall Street is saying about Amazon ahead of earnings 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning EL Estee Lauder $280.46 / +3.53 (+1.27%) 12/17/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 10/20/22 Fly Intel: Pre-market Movers BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo ALGN Align Technology $282.22 / +12.72 (+4.72%) 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning 10/26/22 Fly Intel: After-Hours Movers 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 02/22/23 16th Int'l Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 02/24/23 Annual Meeting of AAAAI 2023 03/17/23 2023 AAD Annual Meeting 08:00 Today Merck - MRK 08:00 Today Sirius XM - SIRI 08:30 Today Quest Diagnostics - DGX 08:30 Today Honeywell - HON 08:30 Today Hershey - HSY 09:00 Today Bristol-Myers - BMY 09:00 Today Penn Entertainment - PENN 09:00 Today Harley-Davidson - HOG 09:30 Today Estee Lauder - EL 10:00 Today Eli Lilly - LLY 03/16/23 FedEx - FDX 06/16/23 PDUFA Date for CAMZYOS SIRI QRVO PENN MRK META LLY HSY HON HOG FDX EL BMY ALGN SIRI Sirius XM $5.84 / +0.06 (+1.04%) 02/01/23 Sirius XM put volume heavy and directionally bearish 01/05/23 Largest borrow rate increases among liquid names 12/30/22 Sirius XM call volume above normal and directionally bullish 12/22/22 Sirius XM put volume heavy and directionally bearish QRVO Qorvo $113.56 / +4.91 (+4.52%) 02/01/23 Qorvo options imply 5.2% move in share price post-earnings PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 12/14/22 Penn National call volume above normal and directionally bullish 12/09/22 Unusually active option classes on open December 9th 12/08/22 Penn National put volume heavy and directionally bearish 11/14/22 Penn National call volume above normal and directionally bullish MRK Merck $106.94 / -0.48 (-0.45%) 01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th 10/10/22 Early notable gainers among liquid option names on October 10th META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta Platforms (Facebook) options imply 8.9% move in share price post-earnings 01/10/23 Notable open interest changes for January 10th 01/04/23 Meta Platforms (Facebook) call volume above normal and directionally bullish 12/16/22 Early notable gainers among liquid option names on December 16th LLY Eli Lilly $342.49 / -1.61 (-0.47%) 11/01/22 Unusually active option classes on open November 1st 10/03/22 Eli Lilly And Co put volume heavy and directionally bearish 09/28/22 Early notable gainers among liquid option names on September 28th 09/28/22 Unusually active option classes on open September 28th HSY Hershey $225.25 / +0.78 (+0.35%) 11/16/22 Early notable gainers among liquid option names on November 16th HON Honeywell $206.67 / -1.87 (-0.90%) 01/18/23 Honeywell put volume heavy and directionally bearish HOG Harley-Davidson $46.78 / +0.74 (+1.61%) 01/19/23 Harley Davidson call volume above normal and directionally bullish 01/05/23 Unusually active option classes on open January 5th 12/30/22 Unusually active option classes on open December 30th 09/29/22 Unusually active option classes on open September 29th FDX FedEx $202.08 / +8.21 (+4.23%) 12/23/22 Unusually active option classes on open December 23rd 12/22/22 Early notable gainers among liquid option names on December 22nd 12/22/22 Unusually active option classes on open December 22nd 12/15/22 Fedex put volume heavy and directionally bearish EL Estee Lauder $280.46 / +3.53 (+1.27%) 12/21/22 Early notable gainers among liquid option names on December 21st 11/04/22 Early notable gainers among liquid option names on November 4th BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology options imply 9.2% move in share price post-earnings 10/31/22 Early notable gainers among liquid option names on October 31st 10/26/22 Align Technology options imply 11.2% move in share price post-earnings 09/26/22 Align Technology call volume above normal and directionally bullish
Hot Stocks	Exscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318 » 08:09 02/02/23 02/02 08:09 02/02/23 08:09 EXAI Exscientia $8.02 / +0.955 (+13.53%) , BMY Bristol-Myers $71.22 / -1.43 (-1.97%) Exscientia (EXAI)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EXAI BMY EXAI Exscientia $8.02 / +0.955 (+13.53%) 12/06/22 Exscientia presents novel immuno-oncology biomarker for EXS-21546 11/14/22 Exscientia and MD Anderson launch strategic collaboration 09/08/22 Exscientia announces Caroline Rowland as Chief People Officer BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing EXAI BMY EXAI Exscientia $8.02 / +0.955 (+13.53%) 11/16/22 Barclays Exscientia price target lowered to $12 from $40 at Barclays BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse BMY BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 07:03 Today Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 07:02 Today Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 02/01/23 Notable companies reporting before tomorrow's open BMY BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports BMY BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 03/17/23 2023 AAD Annual Meeting 09:00 Today Bristol-Myers - BMY 06/16/23 PDUFA Date for CAMZYOS BMY BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th
Earnings	Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00 » 07:03 02/02/23 02/02 07:03 02/02/23 07:03 BMY Bristol-Myers $71.22 / -1.43 (-1.97%) FY23 total revenues are… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 07:02 Today Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 02/01/23 Notable companies reporting before tomorrow's open 10/25/22 Notable companies reporting before tomorrow's open BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 03/17/23 2023 AAD Annual Meeting 09:00 Today Bristol-Myers - BMY 06/16/23 PDUFA Date for CAMZYOS BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th
Earnings	Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72 » 07:02 02/02/23 02/02 07:02 02/02/23 07:02 BMY Bristol-Myers $71.22 / -1.43 (-1.97%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 02/01/23 Notable companies reporting before tomorrow's open 10/25/22 Notable companies reporting before tomorrow's open 10/25/22 Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51 BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 03/17/23 2023 AAD Annual Meeting 09:00 Today Bristol-Myers - BMY 06/16/23 PDUFA Date for CAMZYOS BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th

Yesterday
Earnings	Notable companies reporting before tomorrow's open » 20:25 02/01/23 02/01 20:25 02/01/23 20:25 LLY Eli Lilly $342.49 / -1.61 (-0.47%) , MRK Merck $106.94 / -0.48 (-0.45%) , BMY Bristol-Myers $71.22 / -1.43 (-1.97%) , HON Honeywell $206.67 / -1.87 (-0.90%) , EL Estee Lauder $280.46 / +3.53 (+1.27%) , HSY Hershey $225.25 / +0.78 (+0.35%) , SIRI Sirius XM $5.84 / +0.06 (+1.04%) , CAH Cardinal Health $75.71 / -1.56 (-2.02%) , DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) , PENN Penn Entertainment $35.82 / +0.385 (+1.09%) Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 11/01/22 Sirius XM continues to expect positive 2022 self-pay net subscriber additions 11/01/22 Sirius XM reports Q3 self-pay subscribers 32.3M 11/01/22 Sirius XM raises quarterly cash dividend 10% 10/31/22 Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 12/29/22 Nevada reports November statewide gaming win down 7.62% to $1.22B 12/20/22 New Jersey reports November gaming revenue up 0.3% to $441.1M 12/08/22 Penn Entertainment announces $750M share buyback program MRK Merck $106.94 / -0.48 (-0.45%) 01/27/23 Merck's Keytruda approved by FDA for non-small cell lung cancer treatment 01/26/23 Merck Animal Health announces FDA approval for Bravecto Chews for Dogs 01/25/23 Merck to stop Phase 3 KEYNOTE-991 trial 01/25/23 Merck reports 'positive' results from Phase 3 KEYNOTE-966 trial LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/27/23 Eli Lilly says FDA approves Jaypirca 01/24/23 Eli Lilly trading resumes 01/24/23 Eli Lilly trading halted, volatility trading pause 01/24/23 Eli Lilly to invest $450M to expand manufacturing at Research Triangle Park HSY Hershey $225.25 / +0.78 (+0.35%) 12/07/22 Hershey announces first bilingual manufacturing facility 10/20/22 Hershey signs new solar power purchase agreement with National Grid Renewables 08/31/22 Hershey names Marlene Creighton as Global Chief Sales Officer HON Honeywell $206.67 / -1.87 (-0.90%) 12/19/22 Honeywell confirms resolutions with DOJ, SEC, Brazil for $203M 12/19/22 Honeywell pays $160M to resolve bribery investigations in U.S., Brazil 12/19/22 Honeywell pays $81M to settle SEC Foreign Corrupt Practices charges 12/16/22 Verra Mobility names Jon Keyser as Chief Legal Officer EL Estee Lauder $280.46 / +3.53 (+1.27%) 11/15/22 Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder 11/15/22 Estee Lauder to acquire TOM FORD brand 11/02/22 Estee Lauder raises quarterly dividend 10% to 66c from 60c per share 11/01/22 Mondelez announces three new members to senior management team DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 01/23/23 Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test 12/08/22 Quest Diagnostics partners with Northern Light Health in Maine 12/01/22 Quest Diagnostics awarded group purchasing agreement by Premier 11/28/22 Quest Diagnostics completes acquisition of LabCare CAH Cardinal Health $75.71 / -1.56 (-2.02%) 12/19/22 Cardinal Health announces Aaron Alt as chief financial officer 12/12/22 Yellow Corp appoints Annlea Rumfola as CIO 11/14/22 Elliott made Triple Flag Precious Metals top holding during Q3 09/15/22 PayrHealth announces collaboration with Cardinal Health BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing LLY MRK BMY HON EL HSY SIRI CAH DGX PENN LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/20/23 William Blair Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair 01/12/23 Guggenheim Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks 01/03/23 Barclays Eli Lilly price target raised to $400 from $395 at Barclays 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James MRK Merck $106.94 / -0.48 (-0.45%) 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/04/23 BofA Merck upgraded to Buy at BofA on consistent revenue upside 01/04/23 BofA Merck upgraded to Buy from Neutral at BofA 01/03/23 Wells Fargo Merck price target raised to $125 from $110 at Wells Fargo BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse HON Honeywell $206.67 / -1.87 (-0.90%) 01/04/23 UBS Honeywell downgraded to Sell from Buy at UBS 12/09/22 Citi Honeywell price target raised to $248 from $213 at Citi 12/05/22 Deutsche Bank Honeywell price target raised to $242 from $227 at Deutsche Bank 12/01/22 Barclays Honeywell price target raised to $229 from $212 at Barclays EL Estee Lauder $280.46 / +3.53 (+1.27%) 01/31/23 Jefferies Bath & Body Works price target raised to $52 from $45 at Jefferies 01/24/23 Stifel Estee Lauder price target raised to $295 from $255 at Stifel 01/23/23 Deutsche Bank Estee Lauder price target raised to $290 from $266 at Deutsche Bank 01/17/23 Oppenheimer Estee Lauder price target raised to $300 from $245 at Oppenheimer HSY Hershey $225.25 / +0.78 (+0.35%) 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI 01/03/23 Wells Fargo Hershey initiated with an Underweight at Wells Fargo 12/20/22 Morgan Stanley Hershey price target raised to $231 from $224 at Morgan Stanley 12/08/22 UBS Hershey upgraded to Buy from Neutral at UBS SIRI Sirius XM $5.84 / +0.06 (+1.04%) 01/03/23 JPMorgan Sirius estimates cut on 'challenged' advertising market at JPMorgan 12/01/22 Citi Sirius XM downgraded to Sell from Buy at Citi 11/02/22 Deutsche Bank Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank 11/02/22 Pivotal Research Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research CAH Cardinal Health $75.71 / -1.56 (-2.02%) 01/31/23 UBS Cardinal Health price target raised to $91 from $78 at UBS 11/22/22 Credit Suisse Cardinal Health price target raised to $79 from $64 at Credit Suisse 11/14/22 Mizuho Cardinal Health price target raised to $74 from $66 at Mizuho 11/07/22 Baird Cardinal Health price target raised to $82 from $74 at Baird DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 01/23/23 Evercore ISI Quest Diagnostics initiated with an In Line at Evercore ISI 01/12/23 Baird Quest Diagnostics price target raised to $154 from $143 at Baird 12/14/22 Mizuho Quest Diagnostics price target raised to $165 from $160 at Mizuho 11/17/22 Citi Quest Diagnostics downgraded to Sell from Neutral at Citi PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/20/23 JMP Securities Penn Entertainment price target lowered to $45 from $48 at JMP Securities 01/11/23 Truist Penn Entertainment price target lowered to $36 from $40 at Truist 01/09/23 Jefferies Penn Entertainment downgraded to Hold at Jefferies as focus narrows 01/09/23 Jefferies Penn Entertainment downgraded to Hold from Buy at Jefferies SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 11/01/22 Sirius XM reports Q3 adjusted EPS 7c, consensus 8c 11/01/22 Sirius XM sees FY22 revenue $9B, consensus $9.04B 11/01/22 Sirius XM reports Q3 diluted EPS 6c, consensus 8c PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 11/03/22 Penn Entertainment reports Q3 EPS 72c, consensus 38c 11/02/22 Notable companies reporting before tomorrow's open MRK Merck $106.94 / -0.48 (-0.45%) 10/27/22 Merck raises FY22 adjusted EPS view to $7.32-$7.37 from $7.25-$7.35 10/27/22 Merck reports Q3 adjusted EPS $1.85, consensus $1.71 10/26/22 Notable companies reporting before tomorrow's open LLY Eli Lilly $342.49 / -1.61 (-0.47%) 02/01/23 Notable companies reporting before tomorrow's open 12/13/22 Eli Lilly sees FY23 EPS $8.10-$8.30, consensus $9.15 12/13/22 Eli Lilly backs FY22 EPS view $7.70-$7.85, consensus $7.78 11/01/22 Eli Lilly cuts FY22 EPS view to $7.70-$7.85 from $7.90-$8.05, consensus $7.99 HSY Hershey $225.25 / +0.78 (+0.35%) 11/04/22 Hershey raises FY22 adjusted EPS view to $8.20-$8.27 from $8.05-$8.20 11/04/22 Hershey reports Q3 adjusted EPS $2.17, consensus $2.10 11/03/22 Notable companies reporting before tomorrow's open HON Honeywell $206.67 / -1.87 (-0.90%) 11/18/22 Honeywell reaffirms Q4, 2022 guidance after asbestos settlement 10/27/22 Honeywell sees Q4 adjusted EPS $2.46-$2.56, consensus $2.51 10/27/22 Honeywell narrows FY22 adjusted EPS view to $8.70-$8.80 from $8.55-$8.80 EL Estee Lauder $280.46 / +3.53 (+1.27%) 11/02/22 Estee Lauder cuts FY23 adjusted EPS view to $5.25-$5.40. from $7.39-7.54 11/02/22 Estee Lauder sees Q2 adjusted EPS $1.19-$1.29, consensus $2.81 11/02/22 Estee Lauder reports Q1 EPS $1.37, consensus $1.31 DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 10/20/22 Quest Diagnostics raises FY22 adjusted EPS view to $9.75-$9.95 from $9.55-$9.95 10/20/22 Quest Diagnostics reports Q3 adjusted EPS $2.36, consensus $2.19 CAH Cardinal Health $75.71 / -1.56 (-2.02%) 11/04/22 Cardinal Health backs FY23 EPS view $5.05-$5.40, consensus $5.24 11/04/22 Cardinal Health reports Q1 EPS $1.20, consensus 94c BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 10/25/22 Notable companies reporting before tomorrow's open 10/25/22 Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51 10/25/22 Bristol-Myers reports Q3 EPS $1.99, consensus $1.83 SIRI MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 12/01/22 Sirius XM to cut staff amid faltering sales growth, Bloomberg reports 12/01/22 Sirius XM to reduce staff in coming weeks, Bloomberg reports 08/31/22 James Van Der Beek sues SiriusXM over podcast deal, THR reports MRK Merck $106.94 / -0.48 (-0.45%) 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports LLY Eli Lilly $342.49 / -1.61 (-0.47%) 12/19/22 Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports 10/11/22 New quality issues found at Eli Lilly drug plant, Reuters reports 08/13/22 Eli Lilly, Novo Nordisk weight-loss drugs could be blockbusters, Barron's says HSY Hershey $225.25 / +0.78 (+0.35%) 12/30/22 Hershey sued over metals content in dark chocolate, Reuters says 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure HON Honeywell $206.67 / -1.87 (-0.90%) 09/19/22 Defense companies urged to limit use of Chinese supplies, WSJ reports EL Estee Lauder $280.46 / +3.53 (+1.27%) 11/16/22 Zegna to acquire rest of Tom Ford International, Bloomberg reports 11/15/22 Estee Lauder to acquire Tom Ford in deal valued at $2.8B, WSJ reports 11/15/22 Estee Lauder nearing deal to acquire Tom Ford for $2.8B, WSJ reports 11/11/22 Estee Lauder near deal to acquire Tom Ford for $2.8B, FT reports DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 12/19/22 Doctors gain confidence in new Alzheimer's blood tests, Bloomberg reports CAH Cardinal Health $75.71 / -1.56 (-2.02%) 09/22/22 Activist Elliott would like to see Pinterest put up for sale, Barron's says 08/15/22 Elliott has large stake in Cardinal Health, seeks board seats, WSJ says BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/01/22 Fly Intel: Pre-market Movers PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 01/20/23 Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization 01/13/23 Bet On It: PlayUp SPAC deal terminated 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/06/23 Bet On It: Three downstate New York casino licenses now up for grabs MRK Merck $106.94 / -0.48 (-0.45%) 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LLY Eli Lilly $342.49 / -1.61 (-0.47%) 01/23/23 Biotech Alert: Searches spiking for these stocks today 01/20/23 What You Missed On Wall Street This Morning 01/20/23 Fly Intel: Pre-market Movers 12/19/22 What You Missed On Wall Street On Monday HSY Hershey $225.25 / +0.78 (+0.35%) 01/07/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning HON Honeywell $206.67 / -1.87 (-0.90%) 11/18/22 What You Missed On Wall Street On Friday 10/27/22 What You Missed On Wall Street On Thursday EL Estee Lauder $280.46 / +3.53 (+1.27%) 12/17/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations DGX Quest Diagnostics $148.64 / +0.035 (+0.02%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 10/20/22 Fly Intel: Pre-market Movers CAH Cardinal Health $75.71 / -1.56 (-2.02%) 11/04/22 Fly Intel: Pre-market Movers 09/28/22 #SocialStocks: Details of Musk's deposition by Twitter still being hammered out 08/15/22 What You Missed On Wall Street On Monday 08/11/22 Fly Intel: Pre-market Movers BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 02/01/23 Emerging Biotechnology 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 02/22/23 16th Int'l Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 02/24/23 Annual Meeting of AAAAI 2023 03/17/23 2023 AAD Annual Meeting 08:00 Today Merck - MRK 08:00 Today Sirius XM - SIRI 08:30 Today Quest Diagnostics - DGX 08:30 Today Cardinal Health - CAH 08:30 Today Honeywell - HON 08:30 Today Hershey - HSY 09:00 Today Bristol-Myers - BMY 09:00 Today Penn Entertainment - PENN 09:30 Today Estee Lauder - EL 10:00 Today Eli Lilly - LLY 06/16/23 PDUFA Date for CAMZYOS SIRI PENN MRK LLY HSY HON EL CAH BMY SIRI Sirius XM $5.84 / +0.06 (+1.04%) 02/01/23 Sirius XM put volume heavy and directionally bearish 01/05/23 Largest borrow rate increases among liquid names 12/30/22 Sirius XM call volume above normal and directionally bullish 12/22/22 Sirius XM put volume heavy and directionally bearish PENN Penn Entertainment $35.82 / +0.385 (+1.09%) 12/14/22 Penn National call volume above normal and directionally bullish 12/09/22 Unusually active option classes on open December 9th 12/08/22 Penn National put volume heavy and directionally bearish 11/14/22 Penn National call volume above normal and directionally bullish MRK Merck $106.94 / -0.48 (-0.45%) 01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th 10/10/22 Early notable gainers among liquid option names on October 10th LLY Eli Lilly $342.49 / -1.61 (-0.47%) 11/01/22 Unusually active option classes on open November 1st 10/03/22 Eli Lilly And Co put volume heavy and directionally bearish 09/28/22 Early notable gainers among liquid option names on September 28th 09/28/22 Unusually active option classes on open September 28th HSY Hershey $225.25 / +0.78 (+0.35%) 11/16/22 Early notable gainers among liquid option names on November 16th HON Honeywell $206.67 / -1.87 (-0.90%) 01/18/23 Honeywell put volume heavy and directionally bearish EL Estee Lauder $280.46 / +3.53 (+1.27%) 12/21/22 Early notable gainers among liquid option names on December 21st 11/04/22 Early notable gainers among liquid option names on November 4th CAH Cardinal Health $75.71 / -1.56 (-2.02%) 12/02/22 Early notable gainers among liquid option names on December 2nd 11/11/22 Cardinal Health put volume heavy and directionally bearish 10/10/22 Cardinal Health call volume above normal and directionally bullish 08/12/22 Early notable gainers among liquid option names on August 12th BMY Bristol-Myers $71.22 / -1.43 (-1.97%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th
Earnings	Notable companies reporting before tomorrow's open » 13:50 02/01/23 02/01 13:50 02/01/23 13:50 LLY Eli Lilly $341.25 / -2.85 (-0.83%) , MRK Merck $106.88 / -0.54 (-0.50%) , BMY Bristol-Myers $71.21 / -1.44 (-1.98%) , HON Honeywell $205.59 / -2.95 (-1.41%) , EL Estee Lauder $276.61 / -0.32 (-0.12%) , HSY Hershey $224.88 / +0.41 (+0.18%) , SIRI Sirius XM $5.80 / +0.015 (+0.26%) , CAH Cardinal Health $75.82 / -1.45 (-1.88%) , DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) , PENN Penn Entertainment $35.10 / -0.335 (-0.95%) Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Eli Lilly (LLY), consensus $1.81... Merck (MRK), consensus $1.54... Bristol-Myers (BMY), consensus $1.72... Honeywell (HON), consensus $2.51... Estee Lauder (EL), consensus $1.30... Hershey (HSY), consensus $1.77... Sirius XM (SIRI), consensus 8c... Cardinal Health (CAH), consensus $1.14... Quest Diagnostics (DGX), consensus $1.91... Harley-Davidson (HOG), consensus 6c... Penn Entertaiment (PENN), consensus 41c. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.80 / +0.015 (+0.26%) 11/01/22 Sirius XM continues to expect positive 2022 self-pay net subscriber additions 11/01/22 Sirius XM reports Q3 self-pay subscribers 32.3M 11/01/22 Sirius XM raises quarterly cash dividend 10% 10/31/22 Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles PENN Penn Entertainment $35.10 / -0.335 (-0.95%) 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 12/29/22 Nevada reports November statewide gaming win down 7.62% to $1.22B 12/20/22 New Jersey reports November gaming revenue up 0.3% to $441.1M 12/08/22 Penn Entertainment announces $750M share buyback program MRK Merck $106.88 / -0.54 (-0.50%) 01/27/23 Merck's Keytruda approved by FDA for non-small cell lung cancer treatment 01/26/23 Merck Animal Health announces FDA approval for Bravecto Chews for Dogs 01/25/23 Merck to stop Phase 3 KEYNOTE-991 trial 01/25/23 Merck reports 'positive' results from Phase 3 KEYNOTE-966 trial LLY Eli Lilly $341.25 / -2.85 (-0.83%) 01/27/23 Eli Lilly says FDA approves Jaypirca 01/24/23 Eli Lilly trading resumes 01/24/23 Eli Lilly trading halted, volatility trading pause 01/24/23 Eli Lilly to invest $450M to expand manufacturing at Research Triangle Park HSY Hershey $224.88 / +0.41 (+0.18%) 12/07/22 Hershey announces first bilingual manufacturing facility 10/20/22 Hershey signs new solar power purchase agreement with National Grid Renewables 08/31/22 Hershey names Marlene Creighton as Global Chief Sales Officer HON Honeywell $205.59 / -2.95 (-1.41%) 12/19/22 Honeywell confirms resolutions with DOJ, SEC, Brazil for $203M 12/19/22 Honeywell pays $160M to resolve bribery investigations in U.S., Brazil 12/19/22 Honeywell pays $81M to settle SEC Foreign Corrupt Practices charges 12/16/22 Verra Mobility names Jon Keyser as Chief Legal Officer EL Estee Lauder $276.61 / -0.32 (-0.12%) 11/15/22 Ermenegildo Zegna to enter long term license for Tom Ford with Estee Lauder 11/15/22 Estee Lauder to acquire TOM FORD brand 11/02/22 Estee Lauder raises quarterly dividend 10% to 66c from 60c per share 11/01/22 Mondelez announces three new members to senior management team DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) 01/23/23 Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test 12/08/22 Quest Diagnostics partners with Northern Light Health in Maine 12/01/22 Quest Diagnostics awarded group purchasing agreement by Premier 11/28/22 Quest Diagnostics completes acquisition of LabCare CAH Cardinal Health $75.82 / -1.45 (-1.88%) 12/19/22 Cardinal Health announces Aaron Alt as chief financial officer 12/12/22 Yellow Corp appoints Annlea Rumfola as CIO 11/14/22 Elliott made Triple Flag Precious Metals top holding during Q3 09/15/22 PayrHealth announces collaboration with Cardinal Health BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 01/31/23 Prothena reports 'positive' topline Phase 1 study results for PRX005 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing LLY MRK BMY HON EL HSY SIRI CAH DGX PENN LLY Eli Lilly $341.25 / -2.85 (-0.83%) 01/20/23 William Blair Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair 01/12/23 Guggenheim Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks 01/03/23 Barclays Eli Lilly price target raised to $400 from $395 at Barclays 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James MRK Merck $106.88 / -0.54 (-0.50%) 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/04/23 BofA Merck upgraded to Buy at BofA on consistent revenue upside 01/04/23 BofA Merck upgraded to Buy from Neutral at BofA 01/03/23 Wells Fargo Merck price target raised to $125 from $110 at Wells Fargo BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse HON Honeywell $205.59 / -2.95 (-1.41%) 01/04/23 UBS Honeywell downgraded to Sell from Buy at UBS 12/09/22 Citi Honeywell price target raised to $248 from $213 at Citi 12/05/22 Deutsche Bank Honeywell price target raised to $242 from $227 at Deutsche Bank 12/01/22 Barclays Honeywell price target raised to $229 from $212 at Barclays EL Estee Lauder $276.61 / -0.32 (-0.12%) 01/31/23 Jefferies Bath & Body Works price target raised to $52 from $45 at Jefferies 01/24/23 Stifel Estee Lauder price target raised to $295 from $255 at Stifel 01/23/23 Deutsche Bank Estee Lauder price target raised to $290 from $266 at Deutsche Bank 01/17/23 Oppenheimer Estee Lauder price target raised to $300 from $245 at Oppenheimer HSY Hershey $224.88 / +0.41 (+0.18%) 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI 01/03/23 Wells Fargo Hershey initiated with an Underweight at Wells Fargo 12/20/22 Morgan Stanley Hershey price target raised to $231 from $224 at Morgan Stanley 12/08/22 UBS Hershey upgraded to Buy from Neutral at UBS SIRI Sirius XM $5.80 / +0.015 (+0.26%) 01/03/23 JPMorgan Sirius estimates cut on 'challenged' advertising market at JPMorgan 12/01/22 Citi Sirius XM downgraded to Sell from Buy at Citi 11/02/22 Deutsche Bank Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank 11/02/22 Pivotal Research Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research CAH Cardinal Health $75.82 / -1.45 (-1.88%) 01/31/23 UBS Cardinal Health price target raised to $91 from $78 at UBS 11/22/22 Credit Suisse Cardinal Health price target raised to $79 from $64 at Credit Suisse 11/14/22 Mizuho Cardinal Health price target raised to $74 from $66 at Mizuho 11/07/22 Baird Cardinal Health price target raised to $82 from $74 at Baird DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) 01/23/23 Evercore ISI Quest Diagnostics initiated with an In Line at Evercore ISI 01/12/23 Baird Quest Diagnostics price target raised to $154 from $143 at Baird 12/14/22 Mizuho Quest Diagnostics price target raised to $165 from $160 at Mizuho 11/17/22 Citi Quest Diagnostics downgraded to Sell from Neutral at Citi PENN Penn Entertainment $35.10 / -0.335 (-0.95%) 01/20/23 JMP Securities Penn Entertainment price target lowered to $45 from $48 at JMP Securities 01/11/23 Truist Penn Entertainment price target lowered to $36 from $40 at Truist 01/09/23 Jefferies Penn Entertainment downgraded to Hold at Jefferies as focus narrows 01/09/23 Jefferies Penn Entertainment downgraded to Hold from Buy at Jefferies SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.80 / +0.015 (+0.26%) 11/01/22 Sirius XM reports Q3 adjusted EPS 7c, consensus 8c 11/01/22 Sirius XM sees FY22 revenue $9B, consensus $9.04B 11/01/22 Sirius XM reports Q3 diluted EPS 6c, consensus 8c 10/31/22 Notable companies reporting before tomorrow's open PENN Penn Entertainment $35.10 / -0.335 (-0.95%) 11/03/22 Penn Entertainment reports Q3 EPS 72c, consensus 38c 11/02/22 Notable companies reporting before tomorrow's open 08/04/22 Penn National reports Q2 EPS 15cvs $1.17 last year MRK Merck $106.88 / -0.54 (-0.50%) 10/27/22 Merck raises FY22 adjusted EPS view to $7.32-$7.37 from $7.25-$7.35 10/27/22 Merck reports Q3 adjusted EPS $1.85, consensus $1.71 10/26/22 Notable companies reporting before tomorrow's open LLY Eli Lilly $341.25 / -2.85 (-0.83%) 12/13/22 Eli Lilly sees FY23 EPS $8.10-$8.30, consensus $9.15 12/13/22 Eli Lilly backs FY22 EPS view $7.70-$7.85, consensus $7.78 11/01/22 Eli Lilly cuts FY22 EPS view to $7.70-$7.85 from $7.90-$8.05, consensus $7.99 11/01/22 Eli Lilly reports Q3 EPS $1.98, consensus $1.96 HSY Hershey $224.88 / +0.41 (+0.18%) 11/04/22 Hershey raises FY22 adjusted EPS view to $8.20-$8.27 from $8.05-$8.20 11/04/22 Hershey reports Q3 adjusted EPS $2.17, consensus $2.10 11/03/22 Notable companies reporting before tomorrow's open HON Honeywell $205.59 / -2.95 (-1.41%) 11/18/22 Honeywell reaffirms Q4, 2022 guidance after asbestos settlement 10/27/22 Honeywell sees Q4 adjusted EPS $2.46-$2.56, consensus $2.51 10/27/22 Honeywell narrows FY22 adjusted EPS view to $8.70-$8.80 from $8.55-$8.80 10/27/22 Honeywell reports Q3 adjusted EPS $2.25, consensus $2.16 EL Estee Lauder $276.61 / -0.32 (-0.12%) 11/02/22 Estee Lauder cuts FY23 adjusted EPS view to $5.25-$5.40. from $7.39-7.54 11/02/22 Estee Lauder sees Q2 adjusted EPS $1.19-$1.29, consensus $2.81 11/02/22 Estee Lauder reports Q1 EPS $1.37, consensus $1.31 11/01/22 Notable companies reporting before tomorrow's open DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) 10/20/22 Quest Diagnostics raises FY22 adjusted EPS view to $9.75-$9.95 from $9.55-$9.95 10/20/22 Quest Diagnostics reports Q3 adjusted EPS $2.36, consensus $2.19 CAH Cardinal Health $75.82 / -1.45 (-1.88%) 11/04/22 Cardinal Health backs FY23 EPS view $5.05-$5.40, consensus $5.24 11/04/22 Cardinal Health reports Q1 EPS $1.20, consensus 94c BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 10/25/22 Notable companies reporting before tomorrow's open 10/25/22 Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51 10/25/22 Bristol-Myers reports Q3 EPS $1.99, consensus $1.83 SIRI MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.80 / +0.015 (+0.26%) 12/01/22 Sirius XM to cut staff amid faltering sales growth, Bloomberg reports 12/01/22 Sirius XM to reduce staff in coming weeks, Bloomberg reports 08/31/22 James Van Der Beek sues SiriusXM over podcast deal, THR reports MRK Merck $106.88 / -0.54 (-0.50%) 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports LLY Eli Lilly $341.25 / -2.85 (-0.83%) 12/19/22 Eli Lilly's Mounjaro, Trulicity added to FDA shortage list, STATNews reports 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports 10/11/22 New quality issues found at Eli Lilly drug plant, Reuters reports 08/13/22 Eli Lilly, Novo Nordisk weight-loss drugs could be blockbusters, Barron's says HSY Hershey $224.88 / +0.41 (+0.18%) 12/30/22 Hershey sued over metals content in dark chocolate, Reuters says 12/19/22 Hershey among brands called out by Consumer Reports for lead exposure HON Honeywell $205.59 / -2.95 (-1.41%) 09/19/22 Defense companies urged to limit use of Chinese supplies, WSJ reports EL Estee Lauder $276.61 / -0.32 (-0.12%) 11/16/22 Zegna to acquire rest of Tom Ford International, Bloomberg reports 11/15/22 Estee Lauder to acquire Tom Ford in deal valued at $2.8B, WSJ reports 11/15/22 Estee Lauder nearing deal to acquire Tom Ford for $2.8B, WSJ reports 11/11/22 Estee Lauder near deal to acquire Tom Ford for $2.8B, FT reports DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) 12/19/22 Doctors gain confidence in new Alzheimer's blood tests, Bloomberg reports CAH Cardinal Health $75.82 / -1.45 (-1.88%) 09/22/22 Activist Elliott would like to see Pinterest put up for sale, Barron's says 08/15/22 Elliott has large stake in Cardinal Health, seeks board seats, WSJ says BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says SIRI PENN MRK LLY HSY HON EL DGX CAH BMY SIRI Sirius XM $5.80 / +0.015 (+0.26%) 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/01/22 Fly Intel: Pre-market Movers PENN Penn Entertainment $35.10 / -0.335 (-0.95%) 01/20/23 Bet On It: Kentucky lawmaker sees momentum towards sports betting legalization 01/13/23 Bet On It: PlayUp SPAC deal terminated 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/06/23 Bet On It: Three downstate New York casino licenses now up for grabs MRK Merck $106.88 / -0.54 (-0.50%) 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LLY Eli Lilly $341.25 / -2.85 (-0.83%) 01/23/23 Biotech Alert: Searches spiking for these stocks today 01/20/23 What You Missed On Wall Street This Morning 01/20/23 Fly Intel: Pre-market Movers 12/19/22 What You Missed On Wall Street On Monday HSY Hershey $224.88 / +0.41 (+0.18%) 01/07/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning HON Honeywell $205.59 / -2.95 (-1.41%) 11/18/22 What You Missed On Wall Street On Friday 10/27/22 What You Missed On Wall Street On Thursday EL Estee Lauder $276.61 / -0.32 (-0.12%) 12/17/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations DGX Quest Diagnostics $146.83 / -1.77 (-1.19%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 10/20/22 Fly Intel: Pre-market Movers CAH Cardinal Health $75.82 / -1.45 (-1.88%) 11/04/22 Fly Intel: Pre-market Movers 09/28/22 #SocialStocks: Details of Musk's deposition by Twitter still being hammered out 08/15/22 What You Missed On Wall Street On Monday 08/11/22 Fly Intel: Pre-market Movers BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 02/01/23 Emerging Biotechnology 03/09/23 Biopharma/Biotech 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 02/22/23 16th Int'l Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 02/24/23 Annual Meeting of AAAAI 2023 03/17/23 2023 AAD Annual Meeting 08:00 Today Merck - MRK 08:00 Today Sirius XM - SIRI 08:30 Today Quest Diagnostics - DGX 08:30 Today Cardinal Health - CAH 08:30 Today Honeywell - HON 08:30 Today Hershey - HSY 09:00 Today Bristol-Myers - BMY 09:00 Today Penn Entertainment - PENN 09:30 Today Estee Lauder - EL 10:00 Today Eli Lilly - LLY 06/16/23 PDUFA Date for CAMZYOS SIRI PENN MRK LLY HSY HON EL CAH BMY SIRI Sirius XM $5.80 / +0.015 (+0.26%) 01/05/23 Largest borrow rate increases among liquid names 12/30/22 Sirius XM call volume above normal and directionally bullish 12/22/22 Sirius XM put volume heavy and directionally bearish 12/06/22 Largest borrow rate increases among liquid names PENN Penn Entertainment $35.10 / -0.335 (-0.95%) 12/14/22 Penn National call volume above normal and directionally bullish 12/09/22 Unusually active option classes on open December 9th 12/08/22 Penn National put volume heavy and directionally bearish 11/14/22 Penn National call volume above normal and directionally bullish MRK Merck $106.88 / -0.54 (-0.50%) 01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th 10/10/22 Early notable gainers among liquid option names on October 10th LLY Eli Lilly $341.25 / -2.85 (-0.83%) 11/01/22 Unusually active option classes on open November 1st 10/03/22 Eli Lilly And Co put volume heavy and directionally bearish 09/28/22 Early notable gainers among liquid option names on September 28th 09/28/22 Unusually active option classes on open September 28th HSY Hershey $224.88 / +0.41 (+0.18%) 11/16/22 Early notable gainers among liquid option names on November 16th HON Honeywell $205.59 / -2.95 (-1.41%) 01/18/23 Honeywell put volume heavy and directionally bearish EL Estee Lauder $276.61 / -0.32 (-0.12%) 12/21/22 Early notable gainers among liquid option names on December 21st 11/04/22 Early notable gainers among liquid option names on November 4th CAH Cardinal Health $75.82 / -1.45 (-1.88%) 12/02/22 Early notable gainers among liquid option names on December 2nd 11/11/22 Cardinal Health put volume heavy and directionally bearish 10/10/22 Cardinal Health call volume above normal and directionally bullish 08/12/22 Early notable gainers among liquid option names on August 12th BMY Bristol-Myers $71.21 / -1.44 (-1.98%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:03 02/01/23 02/01 10:03 02/01/23 10:03 FL Foot Locker $44.41 / +0.91 (+2.09%) , NKE Nike $127.22 / -0.115 (-0.09%) , TRU TransUnion $72.77 / +1.02 (+1.42%) , HUBB Hubbell $231.59 / +2.52 (+1.10%) , NEO NeoGenomics $12.45 / +0.57 (+4.80%) , LX LexinFintech $3.75 / +0.425 (+12.80%) , FINV FinVolution Group $5.82 / +0.33 (+6.01%) , AMD AMD $79.97 / +4.78 (+6.36%) , EA Electronic Arts $113.09 / -15.4 (-11.99%) , SNAP Snap $9.94 / -1.605 (-13.91%) , AAPL Apple $142.77 / -1.5 (-1.04%) , FNKO Funko $11.64 / -0.475 (-3.92%) , HAS Hasbro $58.94 / -0.285 (-0.48%) , SHOP Shopify $49.36 / +0.085 (+0.17%) , GIS General Mills $78.11 / -0.24 (-0.31%) , MAT Mattel $20.55 / +0.1 (+0.49%) , RCKT Rocket Pharmaceuticals $21.66 / -0.06 (-0.28%) , BEAM Beam Therapeutics $43.81 / +0.35 (+0.81%) Institutional investors… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TRU SNAP SHOP RCKT NKE NEO MAT LX HUBB HAS GIS FNKO FL FINV EA BEAM AMD AAPL TRU TransUnion $72.77 / +1.02 (+1.42%) 01/31/23 TransUnion announces investment in Bud to drive innovation, growth 01/03/23 Stellex Capital affiliate acquires G2, LCI, and Fintellix from TransUnion 12/13/22 TransUnion to sell G2, LCI and Fintellix for $176M 11/29/22 TransUnion's Q3 industry report shows growth in Canadian credit market SNAP Snap $9.94 / -1.605 (-13.91%) 02/01/23 Snap falls -13.8% 02/01/23 Snap falls -12.2% 01/31/23 Snap expects to see full benefit of cost reductions in Q1 01/31/23 Snap sees Q1 DAU 382M-384M, expects adjusted EBITDA breakeven in Q1 SHOP Shopify $49.36 / +0.085 (+0.17%) 01/25/23 Shopify announces changes to 2023 plan pricing 01/24/23 Shopify trading resumes 01/24/23 Shopify trading halted, volatility trading pause 12/29/22 Bridgeline, Shopify partner for prescriptive marketing dashboard eCommerce360 RCKT Rocket Pharmaceuticals $21.66 / -0.06 (-0.28%) 01/09/23 Rocket Pharmaceuticals adds RP-A601, PKP2-ACM to gene therapy portfolio 12/22/22 Rocket Pharmaceuticals provides update on registration path for RP-A501 12/12/22 Rocket Pharmaceuticals presents clinical data from LV-based gene therapy program 10/12/22 Rocket Pharmaceuticals to present lentiviral gene therapies at ESGCT Congress NKE Nike $127.22 / -0.115 (-0.09%) 01/24/23 Nike trading resumes 01/24/23 Nike trading halted, volatility trading pause 12/21/22 Nike Training Club on Netflix launches December 30 12/21/22 Nike rises 13.7% NEO NeoGenomics $12.45 / +0.57 (+4.80%) 12/05/22 NeoGenomics names Jeffrey Sherman as new CFO 11/21/22 NeoGenomics presents new data on RaDaR Assay across early breast cancer 11/18/22 NeoGenomics, ImmunoGen launche new program for ovarian cancer patients 10/28/22 NeoGenomics provides update on MolDX submission for CRC MAT Mattel $20.55 / +0.1 (+0.49%) 01/31/23 Mattel, Minecraft announce partnership 01/09/23 Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers 10/25/22 Mattel says price increase not producing 'meaningful impact on demand' 10/25/22 Mattel says re-evaluating outlook for FY23, expects top and bottom line growth LX LexinFintech $3.75 / +0.425 (+12.80%) 12/30/22 LexinFintech announces resignation of CFO Sunny Rui Sun HUBB Hubbell $231.59 / +2.52 (+1.10%) 10/21/22 Hubbell board approves share repurchase authorization of up to $300M 10/21/22 Hubbell announces 7% dividend increase HAS Hasbro $58.94 / -0.285 (-0.48%) 01/26/23 Hasbro falls 4% to $61.21 after below-consensus Q4 pre-announcement 01/26/23 Hasbro COO Eric Nyman steps down 01/26/23 Hasbro to eliminate 1,000 full-time positions in 2023 11/17/22 Ancora 'encouraged' by Hasbro's decision to initiate sales process for eOne GIS General Mills $78.11 / -0.24 (-0.31%) 01/11/23 ICL signs strategic partnership agreement with General Mills 12/05/22 IHOP and General Mills partner to turn the brand's iconic pancakes into cereal 11/14/22 General Mills director Cordani sells 26,100 common shares 10/03/22 General Mills exec sells $2.0M in common stock FNKO Funko $11.64 / -0.475 (-3.92%) 01/24/23 42West/BHI client Funko, Snoop Dogg open 'Tha Dogg House' 12/05/22 Funko jumps 4% to $10.85 after announcing management changes 12/05/22 Funko names Brian Mariotti as new CEO, Scott Yessner as interim CFO 11/04/22 Funko trading resumes FL Foot Locker $44.41 / +0.91 (+2.09%) 11/29/22 Foot Locker announces leadership team appointments 11/18/22 Foot Locker rises 14.7% 11/18/22 Foot Locker rises 15.8% 11/18/22 Foot Locker says sustained momentum throughout Q3 FINV FinVolution Group $5.82 / +0.33 (+6.01%) 08/22/22 FinVolution Group expands share repurchase program to $140M EA Electronic Arts $113.09 / -15.4 (-11.99%) 01/31/23 Chairman of Electronic Arts Wilson sells 5,000 shares of company stock 01/31/23 Electronic Arts sees mid-single digit growth in net bookings in 2024 01/31/23 Electronic Arts says taking more measured approach to Q4 game launches 01/31/23 EA says 'FIFA Mobile' engagement up triple digits in Q3 BEAM Beam Therapeutics $43.81 / +0.35 (+0.81%) 01/19/23 Cathie Wood's ARK Investment bought 52.8K shares of Beam Therapeutics today 12/11/22 Beam Therapeutics announces preclinical data from ESCAPE conditioning approach 12/02/22 Beam Therapeutics jumps 11% to $51.00 after FDA lifts hold on IND for BEAM-201 12/02/22 Beam Therapeutics: FDA lifts clinical hold on IND application for BEAM-201 AMD AMD $79.97 / +4.78 (+6.36%) 01/20/23 AMD identified as respondent in ITC investigation of certain integrated circuits 01/19/23 AMD adaptive computing tech enables DENSO LiDAR system 01/11/23 AMD CFO Devinder Kumar to retire, Jean Hu appointed new CFO 12/20/22 EU opens antitrust probe into Broadcom's proposed $61B VMware bid AAPL Apple $142.77 / -1.5 (-1.04%) 02/01/23 Rackspace Technology appoints Roberts to board of directors 01/31/23 Mobile phone, PC shipments to fall another 4.4% in 2023, Gartner says 01/30/23 Apple analyst Ming-Chi Kuo says company to release foldable iPad in 2024 01/20/23 Apple appeals UK competition watchdog investigation FL NKE TRU HUBB NEO LX FINV AMD EA SNAP AAPL FNKO HAS SHOP GIS MAT RCKT BEAM FL Foot Locker $44.41 / +0.91 (+2.09%) 02/01/23 Credit Suisse Foot Locker upgraded to Outperform from Neutral at Credit Suisse 11/28/22 Goldman Sachs Goldman finds small crowds, more promotions over Black Friday weekend 11/21/22 Barclays Foot Locker price target raised to $40 from $38 at Barclays 11/21/22 Deutsche Bank Foot Locker price target raised to $36 from $31 at Deutsche Bank NKE Nike $127.22 / -0.115 (-0.09%) 01/26/23 Wells Fargo Nike price target raised to $146 from $135 at Wells Fargo 01/26/23 JPMorgan Nike price target raised to $156 from $128 at JPMorgan 01/23/23 Cowen Skechers upgraded to Outperform at Cowen on momentum and margin recovery TRU TransUnion $72.77 / +1.02 (+1.42%) 02/01/23 BofA TransUnion upgraded to Buy from Neutral at BofA 01/13/23 Wells Fargo TransUnion upgraded to Overweight from Equal Weight at Wells Fargo 01/13/23 Wells Fargo TransUnion upgraded to Overweight from Equal Weight at Wells Fargo 01/06/23 Exane BNP Paribas TransUnion initiated with a Neutral at Exane BNP Paribas HUBB Hubbell $231.59 / +2.52 (+1.10%) 02/01/23 JPMorgan Hubbell upgraded to Neutral following de-rating at JPMorgan 02/01/23 JPMorgan Hubbell upgraded to Neutral from Underweight at JPMorgan 01/04/23 UBS Hubbell downgraded to Sell from Neutral at UBS 12/28/22 Stephens Stephens carries over seven stocks to 'Best Ideas' list for 2023 NEO NeoGenomics $12.45 / +0.57 (+4.80%) 02/01/23 Needham Needham upgrades NeoGenomics to Buy amid revenue and margin growth 02/01/23 Needham NeoGenomics upgraded to Buy from Hold at Needham 11/14/22 Piper Sandler NeoGenomics price target lowered to $18 from $19 at Piper Sandler 08/26/22 Benchmark NeoGenomics downgraded to Hold from Buy at Benchmark LX LexinFintech $3.75 / +0.425 (+12.80%) 02/01/23 UBS UBS upgrades 'second-tier players' LexinFintech, FinVolution to Buy 02/01/23 UBS LexinFintech upgraded to Buy from Neutral at UBS 11/14/22 CLSA LexinFintech upgraded to Accumulate from Reduce at CLSA 06/01/22 CLSA LexinFintech downgraded to Sell from Outperform at CLSA FINV FinVolution Group $5.82 / +0.33 (+6.01%) 02/01/23 UBS FinVolution Group upgraded to Buy from Neutral at UBS 09/29/22 China Renaissance FinVolution Group assumed with a Buy at China Renaissance 08/24/22 Citi FinVolution Group price target raised to $5.68 from $5.33 at Citi AMD AMD $79.97 / +4.78 (+6.36%) 02/01/23 Craig-Hallum Craig-Hallum downgrades AMD to Hold on slowing growth 02/01/23 Northland AMD guidance 'isn't great,' but 'not a disaster,' says Northland 02/01/23 Craig-Hallum AMD downgraded to Hold from Buy at Craig-Hallum 02/01/23 Morgan Stanley AMD's softer outlook 'still could be a relief' after Intel, says Morgan Stanley EA Electronic Arts $113.09 / -15.4 (-11.99%) 02/01/23 BofA Electronic Arts downgraded to Neutral at BofA on lower growth outlook 02/01/23 BofA Electronic Arts downgraded to Neutral from Buy at BofA 02/01/23 Wells Fargo Electronic Arts price target lowered to $120 from $150 at Wells Fargo 02/01/23 Roth MKM Electronic Arts price target lowered to $112 from $131 at Roth Capital SNAP Snap $9.94 / -1.605 (-13.91%) 02/01/23 Truist Snap price target lowered to $8 from $10 at Truist 02/01/23 Rosenblatt Snap price target raised to $10 from $8 at Rosenblatt 02/01/23 Canaccord Snap price target lowered to $11 from $12 at Canaccord 02/01/23 Benchmark Benchmark downgrades 'too far behind' Snap to Hold after earnings AAPL Apple $142.77 / -1.5 (-1.04%) 01/31/23 UBS Apple iPhone sell-through down 12% in Q4, says UBS 01/30/23 Wells Fargo Wells Fargo near-term cautious on Apple into upcoming Q1 earnings 01/30/23 Credit Suisse Credit Suisse remains bullish on Apple, sees potential upside to estimates FNKO Funko $11.64 / -0.475 (-3.92%) 01/31/23 Goldman Sachs Goldman assumes Funko, downgrades to Sell on execution risk 01/31/23 Goldman Sachs Funko downgraded to Sell from Neutral at Goldman Sachs 01/12/23 Jefferies Funko downgraded to Hold from Buy at Jefferies 01/04/23 BMO Capital Funko likely had 'decent holiday', says BMO Capital HAS Hasbro $58.94 / -0.285 (-0.48%) 01/31/23 Goldman Sachs Hasbro assumed with Neutral from Buy at Goldman Sachs 01/27/23 BMO Capital Hasbro pre-announcement neither shocking nor surprising, says BMO Capital 01/27/23 MKM Partners Hasbro price target lowered to $74 from $80 at MKM Partners 01/27/23 DA Davidson Hasbro price target lowered to $95 from $113 at DA Davidson SHOP Shopify $49.36 / +0.085 (+0.17%) 02/01/23 Scotiabank Scotiabank starts Shopify at Sector Perform on 'robust' valuation 02/01/23 Morgan Stanley Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley 01/31/23 Scotiabank Shopify initiated with a Sector Perform at Scotiabank 01/30/23 UBS Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS GIS General Mills $78.11 / -0.24 (-0.31%) 02/01/23 Stifel Stifel not surprised by potential competitive entrant from Blue Buffalo 02/01/23 Mizuho General Mills initiated with a Neutral at Mizuho 01/26/23 UBS General Mills upgraded to Buy from Neutral at UBS 01/03/23 Wells Fargo General Mills initiated with an Equal Weight at Wells Fargo MAT Mattel $20.55 / +0.1 (+0.49%) 01/31/23 Goldman Sachs Mattel assumed with a Buy at Goldman Sachs 10/26/22 DA Davidson Mattel price target lowered to $31 from $45 at DA Davidson 10/13/22 Jefferies Mattel price target lowered to $22, transferred with a Hold at Jefferies 10/05/22 Stifel Hasbro price target lowered to $84 from $99 at Stifel RCKT Rocket Pharmaceuticals $21.66 / -0.06 (-0.28%) 02/01/23 Morgan Stanley Rocket Pharmaceuticals initiated with an Overweight at Morgan Stanley 12/23/22 BofA Rocket Pharmaceuticals stock reaction looks 'overdone,' says BofA 12/22/22 William Blair William Blair remains bullish on Rocket following FDA discussion commentary 12/22/22 UBS Rocket Pharmaceuticals weakness a buying opportunity, says UBS BEAM Beam Therapeutics $43.81 / +0.35 (+0.81%) 02/01/23 Cantor Fitzgerald Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald 01/31/23 Cantor Fitzgerald Beam Therapeutics initiated with an Overweight at Cantor Fitzgerald 12/20/22 BMO Capital Beam Therapeutics upgraded to Outperform from Market Perform at BMO Capital 12/13/22 Citi Beam Therapeutics initiated with a Buy at Citi TRU SNAP SHOP RCKT NKE NEO MAT HUBB HAS GIS FNKO FL EA BEAM AMD AAPL TRU TransUnion $72.77 / +1.02 (+1.42%) 10/25/22 TransUnion sees FY22 adjusted EPS $3.63-$3.69, consensus $3.73 10/25/22 TransUnion sees Q4 adjusted EPS 80c-86c, consensus 81c 10/25/22 TransUnion sees FY22 organic revenue growth approximately 7% 10/25/22 TransUnion reports Q3 adjusted EPS 93c, consensus 91c SNAP Snap $9.94 / -1.605 (-13.91%) 01/31/23 Snap sees Q1 revenue down 2%-10% y/y, consensus $1.08B 01/31/23 Snap reports Q4 EPS 14c, consensus 11c 10/20/22 Snap reports Q3 adjusted EPS 8c, consensus (1c) SHOP Shopify $49.36 / +0.085 (+0.17%) 10/27/22 Shopify reports Q3 adjusted EPS (2c), consensus (10c) 10/26/22 Notable companies reporting before tomorrow's open RCKT Rocket Pharmaceuticals $21.66 / -0.06 (-0.28%) 11/03/22 Rocket Pharmaceuticals reports Q3 EPS (87c), consensus (79c) 08/08/22 Rocket Pharmaceuticals reports Q2 EPS (83c), consensus (68c) NKE Nike $127.22 / -0.115 (-0.09%) 12/20/22 Nike sees FY23 revenue growth in mid teens, consensus $49.01B 12/20/22 Nike reports Q2 EPS 85c, consensus 65c 12/20/22 Notable companies reporting after market close 09/29/22 Nike reports Q1 EPS 93c, consensus 92c NEO NeoGenomics $12.45 / +0.57 (+4.80%) 11/08/22 NeoGenomics Q3 adjusted EPS (14c), consensus (21c) 08/09/22 NeoGenomics reports Q2 EPS (28c), consensus (22c) 08/09/22 NeoGenomics reports Q2 revenue $125M, consensus $123.33M MAT Mattel $20.55 / +0.1 (+0.49%) 10/25/22 Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48 10/25/22 Mattel reports Q3 EPS 82c, consensus 74c 10/25/22 Notable companies reporting after market close HUBB Hubbell $231.59 / +2.52 (+1.10%) 01/31/23 Hubbell sees FY23 adjusted EPS $11.00-$11.50, consensus $11.14 01/31/23 Hubbell reports Q4 adjusted EPS $2.60, consensus $2.38 10/25/22 Hubbell raises FY22 adjusted EPS view $10.25-$10.45 from $9.40-$9.80 10/25/22 Hubbell reports Q3 adjusted EPS $3.08, consensus $2.71 HAS Hasbro $58.94 / -0.285 (-0.48%) 01/26/23 Hasbro sees FY22 EPS $4.43-$4.45, consensus $4.64 01/26/23 Hasbro reports preliminary Q4 EPS of $1.29-$1.31, consensus $1.48 10/18/22 Hasbro backs FY22 revenue view flat to slightly down in constant currency 10/18/22 Hasbro reports Q3 adjusted EPS $1.42, consensus $1.52 GIS General Mills $78.11 / -0.24 (-0.31%) 12/20/22 General Mills raises FY23 adjusted EPS view to up 4%-6% from up 2%-5% 12/20/22 General Mills reports Q2 adjusted EPS $1.10, consensus $1.06 12/19/22 Notable companies reporting before tomorrow's open FNKO Funko $11.64 / -0.475 (-3.92%) 11/03/22 Funko cuts FY22 EPS view to 85c-95c from $1.88-$1.99, consensus $1.90 11/03/22 Funko reports Q3 EPS 19c, consensus 50c 08/04/22 Funko raises FY22 EPS view to $1.88-$1.99 from $1.80-$1.90 08/04/22 Funko reports Q2 adjusted EPS 26c, consensus 23c FL Foot Locker $44.41 / +0.91 (+2.09%) 11/18/22 Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45 11/18/22 Foot Locker sees Q4 EPS 45c-53c, consensus 43c 11/18/22 Foot Locker reports Q3 EPS $1.27, consensus $1.11 11/17/22 Notable companies reporting before tomorrow's open EA Electronic Arts $113.09 / -15.4 (-11.99%) 01/31/23 EA sees mid-single digit top and bottom line growth in FY24 01/31/23 Electronic Arts cuts FY23 EPS view to $2.97-$3.11 from $3.11-$3.34 01/31/23 Electronic Arts sees Q4 EPS 5c-20c, consensus $2.22 01/31/23 Electronic Arts reports Q3 EPS 73, consensus $3.05 BEAM Beam Therapeutics $43.81 / +0.35 (+0.81%) 11/07/22 Beam Therapeutics reports Q3 EPS ($1.56), consensus ($1.31) 08/09/22 Beam Therapeutics reports Q2 EPS ($1.02), consensus ($1.08) AMD AMD $79.97 / +4.78 (+6.36%) 01/31/23 AMD sees Q1 revenue $5.3B +/- $300M, consensus $5.48B 01/31/23 AMD reports Q4 EPS 69c, consensus 67c 01/31/23 Notable companies reporting after market close 11/01/22 AMD cuts FY22 revenue view to $23.5B +/- $300M from $26.3B +/- $300M AAPL Apple $142.77 / -1.5 (-1.04%) 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close 04 Oct TRU SNAP SHOP NKE HAS GIS FL EA AMD AAPL TRU TransUnion $72.77 / +1.02 (+1.42%) 12/15/22 Wyden seeks FTC probe of Neustar's data sales to U.S. government, WaPo reports SNAP Snap $9.94 / -1.605 (-13.91%) 01/25/23 Feds to question Snapchat's role in fentanyl-laced pills sales, Bloomberg says 01/25/23 Hawley to introduce bill to implement nationwide ban on TikTok, Fox reports 01/08/23 Seattle public schools blame tech giants for social media harm, Reuters says 12/22/22 TikTok parent ByteDance says staff improperly accessed user data, WSJ says SHOP Shopify $49.36 / +0.085 (+0.17%) 01/27/23 Shopify CTO Allan Leinwand to depart company, Insider reports 01/03/23 Shopify Audiences a 'key focus' for company, FT reports 10/13/22 E-commerce sites scale back ops amid online shopping shift, Bloomberg reports 09/02/22 Jury says Shopify owes $40M for website IP patent infringement, Reuters reports NKE Nike $127.22 / -0.115 (-0.09%) 12/05/22 Nike cut ties with Kyrie Irving, The Athletic reports 11/25/22 Brookfield acquired Nike label supplier Trimco Group, Bloomberg reports 11/15/22 Nike to open online store for virtual sneakers, Bloomberg reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says HAS Hasbro $58.94 / -0.285 (-0.48%) 01/10/23 Paramount+ orders live-action show based on 'Dungeons & Dragons,' TC says 11/17/22 Hasbro hires advisers to seek buyer for most of EOne, Bloomberg says GIS General Mills $78.11 / -0.24 (-0.31%) 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports 11/03/22 General Mills, Mondelez, Pfizer halt Twitter advertising, WSJ reports FL Foot Locker $44.41 / +0.91 (+2.09%) 10/26/22 Foot Locker to remove Yeezy products from stores, CNBC reports EA Electronic Arts $113.09 / -15.4 (-11.99%) 01/30/23 EA's 'Dead Space' top-selling physical game in U.K., GI.biz says 01/23/23 Nintendo's new 'Fire Emblem' top-selling physical game in U.K., GI.biz says 01/18/23 Video game sales fell 13% y/y in Europe in December, GI.biz says 01/11/23 Amazon Game Studios loses another key executive amid cutbacks, Bloomberg says AMD AMD $79.97 / +4.78 (+6.36%) 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/11/23 TSMC receives 3nm chip orders from Broadcom, DigiTimes reports 01/04/23 China pauses chip industry investments as COVID resurges, Bloomberg reports AAPL Apple $142.77 / -1.5 (-1.04%) 02/01/23 Apple developing micro LED technology, DigiTimes reports 01/31/23 Apple shopping ad packages for MLS Season Pass for $4M/season, Bloomberg says 01/30/23 NLRB says Apple violated employee rights, Bloomberg says 01/30/23 NLRB says Apple violated employee rights, Bloomberg says TRU SNAP SHOP RCKT NKE NEO MAT HUBB HAS GIS FNKO FL EA BEAM AMD AAPL TRU TransUnion $72.77 / +1.02 (+1.42%) 01/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning SNAP Snap $9.94 / -1.605 (-13.91%) 01/31/23 Here's what Wall St. experts are saying about Snap ahead of earnings SHOP Shopify $49.36 / +0.085 (+0.17%) 01/30/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning RCKT Rocket Pharmaceuticals $21.66 / -0.06 (-0.28%) 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 11/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations NKE Nike $127.22 / -0.115 (-0.09%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning NEO NeoGenomics $12.45 / +0.57 (+4.80%) 08/12/22 Sell these stocks now, proven algorithm says MAT Mattel $20.55 / +0.1 (+0.49%) 10/25/22 Fly Intel: After-Hours Movers 08/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations HUBB Hubbell $231.59 / +2.52 (+1.10%) 01/31/23 Fly Intel: Pre-market Movers 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations HAS Hasbro $58.94 / -0.285 (-0.48%) 01/26/23 Fly Intel: After-Hours Movers GIS General Mills $78.11 / -0.24 (-0.31%) 01/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 Fly Insider: Coinbase, Buckle among week's notable insider trades 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations FNKO Funko $11.64 / -0.475 (-3.92%) 12/05/22 Fly Intel: After-Hours Movers 11/04/22 What You Missed On Wall Street On Friday 11/04/22 What You Missed On Wall Street This Morning FL Foot Locker $44.41 / +0.91 (+2.09%) 02/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/18/22 What You Missed On Wall Street On Friday 11/18/22 What You Missed On Wall Street This Morning 11/18/22 Fly Intel: Pre-market Movers EA Electronic Arts $113.09 / -15.4 (-11.99%) 01/31/23 What You Missed This Week in Video Games BEAM Beam Therapeutics $43.81 / +0.35 (+0.81%) 01/23/23 Fly Insider: Appian, Eversource Energy among week's notable insider trades 11/18/22 Sell these stocks now, proven algorithm says 11/07/22 Fly Intel: Pre-market Movers AMD AMD $79.97 / +4.78 (+6.36%) 02/01/23 Fly Intel: Pre-market Movers 01/31/23 Fly Intel: After-Hours Movers 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week AAPL Apple $142.77 / -1.5 (-1.04%) 01/31/23 What Wall Street is saying about Meta ahead of earnings 01/27/23 What You Missed On Wall Street On Friday 01/27/23 What You Missed On Wall Street This Morning 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR 03/06/23 Technology Conference 03/21/23 6th Annual Consumer Growth Conference 17:00 Today Apple - AAPL 02/08/23 Mattel - MAT 02/14/23 TransUnion - TRU 02/15/23 Shopify - SHOP 02/16/23 Hasbro - HAS 05/09/23 Electronic Arts - EA 02/10/23 AMD 03/10/23 Apple, Inc. SNAP SHOP NKE MAT HAS GIS FL FINV EA AMD AAPL SNAP Snap $9.94 / -1.605 (-13.91%) 01/31/23 Snap Inc. options imply 18.8% move in share price post-earnings 12/22/22 Snap Inc. call volume above normal and directionally bullish 12/15/22 Snap Inc. call volume above normal and directionally bullish SHOP Shopify $49.36 / +0.085 (+0.17%) 01/23/23 Unusually active option classes on open January 23rd 01/05/23 Shopify call volume above normal and directionally bullish 01/05/23 Unusually active option classes on open January 5th 01/03/23 Shopify call volume above normal and directionally bullish NKE Nike $127.22 / -0.115 (-0.09%) 12/22/22 Unusually active option classes on open December 22nd 12/21/22 Early notable gainers among liquid option names on December 21st 12/21/22 Notable open interest changes for December 21st 12/20/22 Nike options imply 7.5% move in share price post-earnings MAT Mattel $20.55 / +0.1 (+0.49%) 01/09/23 Mattel put volume heavy and directionally bearish 10/25/22 Mattel options imply 7.0% move in share price post-earnings 10/19/22 Mattel call volume above normal and directionally bullish 10/04/22 Mattel Inc call volume above normal and directionally bullish HAS Hasbro $58.94 / -0.285 (-0.48%) 01/13/23 Hasbro call volume above normal and directionally bullish 09/22/22 Hasbro call volume above normal and directionally bullish GIS General Mills $78.11 / -0.24 (-0.31%) 12/20/22 Unusually active option classes on open December 20th 11/16/22 Early notable gainers among liquid option names on November 16th 09/27/22 General Mills put volume heavy and directionally bearish 09/21/22 Early notable gainers among liquid option names on September 21st FL Foot Locker $44.41 / +0.91 (+2.09%) 01/23/23 Foot Locker call volume above normal and directionally bullish 12/21/22 Unusually active option classes on open December 21st 11/18/22 Unusually active option classes on open November 18th 11/16/22 Foot Locker put volume heavy and directionally bearish FINV FinVolution Group $5.82 / +0.33 (+6.01%) 11/14/22 FinVolution Group options imply 9.8% move in share price post-earnings EA Electronic Arts $113.09 / -15.4 (-11.99%) 01/31/23 Electronic Arts options imply 4.3% move in share price post-earnings 10/05/22 Electronic Arts put volume heavy and directionally bearish 10/03/22 Electronic Arts Inc. call volume above normal and directionally bullish 08/26/22 Early notable gainers among liquid option names on August 26th AMD AMD $79.97 / +4.78 (+6.36%) 02/01/23 Early notable gainers among liquid option names on February 1st 02/01/23 Notable open interest changes for February 1st 01/31/23 Advanced Micro options imply 7.0% move in share price post-earnings 01/24/23 Unusually active option classes on open January 24th AAPL Apple $142.77 / -1.5 (-1.04%) 01/30/23 Notable open interest changes for January 30th 01/26/23 Notable open interest changes for January 26th 01/24/23 Notable open interest changes for January 24th 01/24/23 Apple call buyer realizes 16% same-day gains
Upgrade	Needham upgrades NeoGenomics to Buy amid revenue and margin growth » 07:57 02/01/23 02/01 07:57 02/01/23 07:57 NEO NeoGenomics $11.89 / +0.52 (+4.57%) Needham analyst Mike… Needham analyst Mike Matson upgraded NeoGenomics to Buy from Hold with a $15 price target. The analyst is "more encouraged" by NeoGenomics' revenue and margin growth in recent quarters amid changes to pricing and operational improvements. While management has indicated that 2023 RaDaR sales are not likely to be meaningful, the firm believes that if early adoption signs are encouraging, investor excitement could build heading into 2024. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NEO NeoGenomics $11.89 / +0.52 (+4.57%) 12/05/22 NeoGenomics names Jeffrey Sherman as new CFO 11/21/22 NeoGenomics presents new data on RaDaR Assay across early breast cancer 11/18/22 NeoGenomics, ImmunoGen launche new program for ovarian cancer patients 10/28/22 NeoGenomics provides update on MolDX submission for CRC NEO NeoGenomics $11.89 / +0.52 (+4.57%) 02/01/23 Needham NeoGenomics upgraded to Buy from Hold at Needham 11/14/22 Piper Sandler NeoGenomics price target lowered to $18 from $19 at Piper Sandler 08/26/22 Benchmark NeoGenomics downgraded to Hold from Buy at Benchmark 08/22/22 Needham Needham cuts NeoGenomics to Hold, sees 2023 as 'transition year' NEO NeoGenomics $11.89 / +0.52 (+4.57%) 11/08/22 NeoGenomics Q3 adjusted EPS (14c), consensus (21c) 08/09/22 NeoGenomics reports Q2 EPS (28c), consensus (22c) 08/09/22 NeoGenomics reports Q2 revenue $125M, consensus $123.33M NEO NeoGenomics $11.89 / +0.52 (+4.57%) 08/12/22 Sell these stocks now, proven algorithm says 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference
Upgrade	NeoGenomics upgraded to Buy from Hold at Needham » 05:39 02/01/23 02/01 05:39 02/01/23 05:39 NEO NeoGenomics $11.89 / +0.52 (+4.57%) Needham analyst Mike… Needham analyst Mike Matson upgraded NeoGenomics to Buy from Hold with a $15 price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NEO NeoGenomics $11.89 / +0.52 (+4.57%) 12/05/22 NeoGenomics names Jeffrey Sherman as new CFO 11/21/22 NeoGenomics presents new data on RaDaR Assay across early breast cancer 11/18/22 NeoGenomics, ImmunoGen launche new program for ovarian cancer patients 10/28/22 NeoGenomics provides update on MolDX submission for CRC NEO NeoGenomics $11.89 / +0.52 (+4.57%) 11/14/22 Piper Sandler NeoGenomics price target lowered to $18 from $19 at Piper Sandler 08/26/22 Benchmark NeoGenomics downgraded to Hold from Buy at Benchmark 08/22/22 Needham Needham cuts NeoGenomics to Hold, sees 2023 as 'transition year' 08/22/22 Needham NeoGenomics downgraded to Hold from Buy at Needham NEO NeoGenomics $11.89 / +0.52 (+4.57%) 11/08/22 NeoGenomics Q3 adjusted EPS (14c), consensus (21c) 08/09/22 NeoGenomics reports Q2 EPS (28c), consensus (22c) 08/09/22 NeoGenomics reports Q2 revenue $125M, consensus $123.33M NEO NeoGenomics $11.89 / +0.52 (+4.57%) 08/12/22 Sell these stocks now, proven algorithm says 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference

Tuesday
Hot Stocks	Prothena reports 'positive' topline Phase 1 study results for PRX005 » 16:05 01/31/23 01/31 16:05 01/31/23 16:05 PRTA Prothena $56.23 / +1.25 (+2.27%) , BMY Bristol-Myers $72.48 / +0.45 (+0.62%) Prothena Corporation… Prothena Corporation announced positive topline Phase 1 single ascending dose (SAD) study results for PRX005, a potentially best-in-class investigational tri-epitopic antibody for the treatment of Alzheimer's disease that specifically binds with high affinity to the R1, R2, and R3 repeats within the microtubule binding region (MTBR) of tau and targets both 3R and 4R tau isoforms. PRX005 is one of three programs in the global neuroscience research and development collaboration between Prothena and Bristol Myers Squibb. "For the first time, we have confirmation that PRX005 is safe and well-tolerated in humans and that it crosses the blood-brain barrier with robust central nervous system (CNS) penetration. We developed PRX005 to uniquely target a key region within the MTBR of tau to reduce pathogenic tau uptake into neurons, an attribute that has not been similarly achievable with antibodies targeting other regions of tau. These topline Phase 1 data, together with the mounting scientific evidence suggesting that tau propagation could be mediated by MTBR-tau seeds, underscores the potential of PRX005 in treating Alzheimer's disease," said Gene Kinney, PhD, President and Chief Executive Officer of Prothena. "Working closely with Bristol Myers Squibb, we are combining our expertise to advance the development of PRX005 as quickly as possible, and we look forward to seeing Phase 1 multiple ascending dose (MAD) results in patients with Alzheimer's disease later this year." In this first-in-human, randomized, placebo controlled, SAD study, healthy volunteers (n=19) were enrolled into three PRX005 dose level cohorts (low, medium or high dose) and randomized in a 3:1 drug to placebo ratio. Study participants received a single dose of PRX0005 or placebo intravenously (IV) and were followed for up to two months. The results of the study found all three dose level cohorts of PRX005 to be generally safe and well tolerated, meeting the Phase 1 SAD study primary objective. None of the treatment emergent adverse events (TEAE) were serious. No clinically relevant changes were observed in other safety parameters. PRX005 also met key pharmacokinetic (PK) and immunogenicity secondary endpoints. Plasma drug concentrations of PRX005 increased in a dose-proportional manner. Furthermore, PRX005 exposure in cerebrospinal fluid (CSF) was measured in the high dose cohort and based on the robust exposure of PRX005 in the CSF (day 29 CSF:Plasma ratio=0.2%), substantial target engagement is expected in the CNS. PRX005 had a desirable immunogenicity profile with no persistent PRX005-induced antidrug antibodies (ADAs) observed. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PRTA BMY PRTA Prothena $56.23 / +1.25 (+2.27%) 12/12/22 Prothena presents data from phase 3 VITAL study 11/21/22 Prothena achieves $40M clinical milestone payment from Novo Nordisk 11/03/22 Prothena sees FY22 net cash burn of $108M-$120M, up from $120M-$132M 09/28/22 Prothena up 60% in premarket at $49.59 following Biogen/Eisai data on lecanemab BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 01/27/23 Bristol-Myers announces CHMP opinion recommending approval for Reblozyl 01/27/23 Bristol-Myers' Sotyktu recommended for approval in psoriasis by Europe's CHMP 01/26/23 iVexSol closes $23.8M Series A-3 financing 01/26/23 Bristol-Myers reports TRANSCEND CLL 004 trial of Breyanzi met primary endpoint PRTA BMY PRTA Prothena $56.23 / +1.25 (+2.27%) 01/27/23 Piper Sandler Prothena initiated with an Overweight at Piper Sandler 12/21/22 Cantor Fitzgerald Prothena price target raised to $98 from $91 at Cantor Fitzgerald 11/29/22 Jefferies Prothena data from AD/PD abstract 'promising,' says Jefferies 11/15/22 Oppenheimer Prothena price target raised to $120 from $110 at Oppenheimer BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/17/23 Cantor Fitzgerald Bristol-Myers initiated with an Overweight at Cantor Fitzgerald 12/23/22 William Blair NccRCC 'material expansion opportunity' for Exelixis, says William Blair 11/17/22 Credit Suisse Bristol-Myers initiated with a Neutral at Credit Suisse PRTA BMY PRTA Prothena $56.23 / +1.25 (+2.27%) 11/03/22 Prothena reports Q3 EPS (97c), consensus (53c) 08/08/22 Prothena reports Q2 EPS (88c) vs. 58c last year BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 10/25/22 Notable companies reporting before tomorrow's open 10/25/22 Bristol-Myers affirms FY22 EPS view of $7.44 - $7.74, consensus $7.51 10/25/22 Bristol-Myers reports Q3 EPS $1.99, consensus $1.83 15 Dec BMY BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports PRTA BMY PRTA Prothena $56.23 / +1.25 (+2.27%) 12/13/22 Fly Intel: After-Hours Movers 10/03/22 Biotech Alert: Searches spiking for these stocks today 10/03/22 What You Missed This Week in EVs and Clean Energy 09/28/22 Which Alzheimer's stock may be next to jump after Biogen's 'clean’ win? BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Biotech Alert: Searches spiking for these stocks today 11/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/10/22 Meet Silo Pharma: Fly exclusive interview with CEO Weisblum, VP of R&D Kuo 03/09/23 Biopharma/Biotech 03/17/23 2023 AAD Annual Meeting 09:00 Today Bristol-Myers - BMY 06/16/23 PDUFA Date for CAMZYOS BMY BMY Bristol-Myers $72.48 / +0.45 (+0.62%) 09/29/22 Early notable gainers among liquid option names on September 29th 09/12/22 Early notable gainers among liquid option names on September 12th 09/12/22 Unusually active option classes on open September 12th 09/08/22 Notable open interest changes for September 8th

On The Fly

News and insights, exclusive to thefly.com

18:53	Fly Intel: After-Hours Movers»
16:25	What You Missed On Wall Street On Thursday»
13:56	What Wall Street is saying about Starbucks ahead of earnings»
13:39	What Wall Street is saying about Apple ahead of earnings»
12:31	Here's what Wall Street is saying about Qualcomm ahead of earnings»

View all On The Fly Stories »

Upcoming
Events (10)

FRPT ...	Groundhog Day Investment Forum 2023
	ABA Derivatives and Futures Law Committee Winter Meeting
	International Builders Show: IBS 2023
	NAPE Summit 2023
	Las Vegas Market 2023
	NAFEM Show 2023
	20th Annual Infrastructure & Utilities Conference
PRVB	Provention Bio
INSE	Inspired Entertainment
ACHV	Achieve Life Sciences

View all of today’s events »

Today’s
Syndicate (3)

ALGM	Block Trade
VERA	Spot Secondary
WULF	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial